Literature DB >> 29291253

Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect.

Anuhya Kommalapati1, Shanaz Sikder2, Sri Harsha Tella3.   

Abstract

Entities:  

Year:  2017        PMID: 29291253      PMCID: PMC5744671     

Source DB:  PubMed          Journal:  Res Rev J Hosp Clin Pharm


× No keyword cloud information.
  12 in total

Review 1.  Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue.

Authors:  Gilda Varricchi; Giancarlo Marone; Valentina Mercurio; Maria Rosaria Galdiero; Domenico Bonaduce; Carlo G Tocchetti
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 2.  Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature.

Authors:  A Chauhan; G Burkeen; J Houranieh; S Arnold; L Anthony
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

3.  A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitors.

Authors:  Omar Abdel-Rahman; Mona Fouad
Journal:  Immunotherapy       Date:  2016-05       Impact factor: 4.196

4.  Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Authors:  Omar Abdel-Rahman; Mona Fouad
Journal:  Ther Adv Respir Dis       Date:  2016-03-04       Impact factor: 4.031

Review 5.  Management of toxicities of immune checkpoint inhibitors.

Authors:  Lavinia Spain; Stefan Diem; James Larkin
Journal:  Cancer Treat Rev       Date:  2016-02-06       Impact factor: 12.111

6.  Future perspectives in cancer immunotherapy.

Authors:  Marinos Tsiatas; Giannis Mountzios; Giuseppe Curigliano
Journal:  Ann Transl Med       Date:  2016-07

Review 7.  Neurologic complications of immune checkpoint inhibitors.

Authors:  Andreas F Hottinger
Journal:  Curr Opin Neurol       Date:  2016-12       Impact factor: 5.710

Review 8.  Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis.

Authors:  Omar Abdel-Rahman; Hesham ElHalawani; Mona Fouad
Journal:  Future Oncol       Date:  2016-01-18       Impact factor: 3.404

Review 9.  Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies.

Authors:  Andrew J S Furness; Frederick Arce Vargas; Karl S Peggs; Sergio A Quezada
Journal:  Trends Immunol       Date:  2014-06-18       Impact factor: 16.687

Review 10.  Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

Authors:  Claire F Friedman; Tracy A Proverbs-Singh; Michael A Postow
Journal:  JAMA Oncol       Date:  2016-10-01       Impact factor: 31.777

View more
  1 in total

1.  Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.

Authors:  Xuejun Fan; Zihao Yuan; Yueshui Zhao; Wei Xiong; Hao-Ching Hsiao; Rahmawati Pare; Jianmin Ding; Ahmad Almosa; Kai Sun; Songlin Zhang; Robert E Jordan; Cheok Song Lee; Zhiqiang An; Ningyan Zhang
Journal:  Commun Biol       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.